BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
G-protein-coupled receptor binding
,
Allergy to pollen
,
Intestine
,
Valproic acid
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
S1P- receptor
Summary
General Info
Curated Studies
Most Correlated Studies
Sphingosine-1-phosphate (S1P) effects on U373 MG glioblastoma cells compared to EGF in vitro
Osteoclasts from wildtype and calcitonin receptor knockouts treated with calcitonin
Cardiac myocytes from IPSCs sparsely plated and treated with XMU-MP-1 and sphingosine-1-phosphate
Brain astrocytoma 1321N1 cells with YAP or MRTFA or RHOA knockout and with sphingosine 1-phosphate
Breast cancer MCF7 cells treated with sphingosine-1-phosphate, FTY720 or SAHA
Explore Curated Studies Results
Literature
Most Relevant Literature
S1P/S1PR signaling pathway advancements in autoimmune diseases.
Pharmacokinetics of S1P receptor modulators in the treatment of ulcerative colitis.
Sphingosine 1-phosphate (S1P) receptor modulators as an induction and maintenance therapy for ulcera…
The role of SphK/S1P/S1PR signaling pathway in bone metabolism.
Lessons from S1P receptor targeting in multiple sclerosis.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Activation of the Sphingosine-1-phosphate (S1P) to S1P1 Receptor Subtype (S1PR1) Axis in Patients Wi…
A Study to Assess the Relative Bioavailability of Different Formulations of GSK2018682, a Sphingosin…
Predicting Disease Activity and Rebound Risk in MS Patients Treated With Sphingosine-1-phosphate Rec…
S1P1 Receptor Subtype (S1PR1) Axis in Patients With Interstitial Cystitis (IC) Pain
Monitoring Natural Killer Cells in Multiple Sclerosis Patients Treated With Fingolimod
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ